Latest news
AbCellera to Announce Top-Line Results from the Phase 2 Trial of ABCL635 for the Treatment of Moderate-to-Severe VMS Due to Menopause on Monday, August 10, 2026 - Business WireBusiness Wire · Fri, 07 Aug 2026 20:30:00 GMTJoin Biovie's Exclusive Live Investor Webinar: Inside the SUNRISE-PD Topline Results - Yahoo FinanceYahoo Finance · Fri, 07 Aug 2026 13:00:00 GMTPFE Stock Reacts To Mixed Topline Results For Seagen-Origin Cancer Drug - StocktwitsStocktwits · Fri, 07 Aug 2026 06:47:50 GMTTECX: TX45 Phase 2 trial enrollment completed; topline results expected Q1 2027 - TradingViewTradingView · Thu, 06 Aug 2026 20:27:41 GMTDefinium Therapeutics Reports Second Quarter 2026 Financial Results and Recent Highlights - Business WireBusiness Wire · Thu, 06 Aug 2026 20:01:00 GMTVistagen Announces Topline Results for Repeat Dose Study of - GlobeNewswireGlobeNewswire · Thu, 06 Aug 2026 12:30:00 GMTVistagen's second fasedienol dose showed no new safety findings - Stock TitanStock Titan · Thu, 06 Aug 2026 12:30:00 GMTBioVie Announces Topline Results of Phase 2 SUNRISE-PD Trial of Bezisterim in Early Parkinson’s Disease - GlobeNewswireGlobeNewswire · Thu, 06 Aug 2026 11:30:00 GMT